Demetris Yannopoulos, MD
Interventional Cardiology · Minneapolis, MNNPI 1821143629
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,541 of the $19,945 with a category attached, or 62.9%. 14 manufacturers reported payments, led by Stryker at 39.8% of the total. Reporting peaked in 2020 at $8,123 and has fallen 68.8% since, to $2,536 in 2025.
Across 49 payments — averaging $407.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$8K
- Getinge USA Sales, LLC$4K
- Medtronic$4K
- Maquet Cardiovascular L.L.C.$2K
- Abbott$636
- Edwards Lifesciences$581
- plus $694 from 8 others
Across 1 payment — averaging $16,642 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ZOLL Circulation Inc$17K
What the payments were for
- Consulting fees$12,54163%
- Speaking & faculty fees$4,05520%
- Travel & lodging$980%
- Food & beverage$3,23916%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 4 | $7,930 |
| Getinge USA Sales, LLC | 9 | $4,336 |
| Medtronic(2 entities) | 11 | $3,567 |
| Maquet Cardiovascular L.L.C. | 1 | $2,200 |
| Abbott | 7 | $636 |
| Edwards Lifesciences | 5 | $581 |
| Boston Scientific | 2 | $293 |
| ZOLL Circulation Inc | 1 | $142 |
| Fresenius USA Marketing, Inc. | 1 | $103 |
| Angiodynamics, Inc. | 4 | $82 |
| Cardiovascular Systems Inc. | 1 | $25 |
| Teleflex LLC | 1 | $22 |
| Opsens Inc. | 1 | $15 |
| Chiesi USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LUCAS 3$7,741
- CARDIOHELP$4,202
- Vasoview Hemopro 2$2,200
- 2ND GEN CENTRIMAG PRIMARY CONSOLE$307
- AVVIGO Guidance System$293
- COREVALVE EVOLUT R$260
- CentriMag$244
- SAPIEN 3 Ultra RESILIA$206
- SYMPLICITY G3$164
- CoreValve Evolut$151
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$151
- Resolute$150
- TherOx DS2 Console$142
- Catheter$142
- Downstream Cartridge$142
- MC3 NAUTILUS(TM) ECMO OXYGENATOR$121
- NOVALUNG SYSTEM$103
How this compares
$19,945 in reported general payments places this provider in the 75th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 14 | $224 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Minneapolis
- Emmanouil BrilakisMinneapolis$548K
- Wesley PedersenMinneapolis$493K
- Michael ManolesMinneapolis$201K
- Jay TraverseMinneapolis$198K
- Robert WilsonMinneapolis$176K
- Yale WangMinneapolis$168K
- Steven RohMinneapolis$67K
- Stefan BertogMinneapolis$64K
- Konstantinos VoudrisMinneapolis$46K
- Michael MooneyMinneapolis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.